BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 49 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q2 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $93,529 | -90.6% | 467,411 | -3.7% | 0.00% | – |
| Q2 2023 | $1,000,057 | -36.1% | 485,464 | +2.4% | 0.00% | – |
| Q1 2023 | $1,564,503 | +102.2% | 474,092 | +0.5% | 0.00% | – |
| Q4 2022 | $773,706 | -62.6% | 471,772 | +0.7% | 0.00% | – |
| Q3 2022 | $2,070,000 | +58.3% | 468,320 | -1.1% | 0.00% | – |
| Q2 2022 | $1,308,000 | -17.9% | 473,733 | -0.2% | 0.00% | – |
| Q1 2022 | $1,594,000 | -15.7% | 474,510 | +0.4% | 0.00% | – |
| Q4 2021 | $1,890,000 | +22.2% | 472,476 | +0.7% | 0.00% | – |
| Q3 2021 | $1,547,000 | -14.2% | 468,967 | -1.1% | 0.00% | – |
| Q2 2021 | $1,803,000 | -75.9% | 474,347 | -75.7% | 0.00% | – |
| Q1 2021 | $7,481,000 | -13.9% | 1,953,247 | +1.7% | 0.00% | – |
| Q4 2020 | $8,690,000 | -72.6% | 1,920,340 | +2.5% | 0.00% | -100.0% |
| Q3 2020 | $31,689,000 | +52.1% | 1,872,889 | +0.8% | 0.00% | 0.0% |
| Q2 2020 | $20,829,000 | +1068.9% | 1,858,128 | +383.9% | 0.00% | – |
| Q1 2020 | $1,782,000 | +151.3% | 384,000 | +132.0% | 0.00% | – |
| Q4 2019 | $709,000 | +35.0% | 165,539 | +23.1% | 0.00% | – |
| Q3 2019 | $525,000 | +2.1% | 134,484 | +3.2% | 0.00% | – |
| Q2 2019 | $514,000 | +31.1% | 130,281 | +44.6% | 0.00% | – |
| Q1 2019 | $392,000 | +29.4% | 90,084 | +5.6% | 0.00% | – |
| Q4 2018 | $303,000 | -6.8% | 85,294 | +0.3% | 0.00% | – |
| Q3 2018 | $325,000 | +0.6% | 85,068 | +2.9% | 0.00% | – |
| Q2 2018 | $323,000 | +29.7% | 82,702 | +4.5% | 0.00% | – |
| Q1 2018 | $249,000 | -24.1% | 79,166 | -5.6% | 0.00% | – |
| Q4 2017 | $328,000 | +0.6% | 83,854 | +6.0% | 0.00% | – |
| Q3 2017 | $326,000 | -2.7% | 79,122 | -2.0% | 0.00% | – |
| Q2 2017 | $335,000 | +2.4% | 80,755 | +4.8% | 0.00% | – |
| Q1 2017 | $327,000 | – | 77,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABNER HERRMAN & BROCK LLC | 241,500 | $1,093,000 | 0.17% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 90,584 | $410,000 | 0.13% |
| EPIQ PARTNERS, LLC | 10,550 | $48,000 | 0.03% |
| Phoenix Holdings Ltd. | 173,683 | $799,000 | 0.02% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 5,500 | $25,000 | 0.02% |
| CFO4Life Group, LLC | 12,003 | $54,000 | 0.02% |
| HighPoint Advisor Group LLC | 15,733 | $115,000 | 0.01% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 357,761 | $1,619,000 | 0.01% |
| Virtu Financial LLC | 24,484 | $111,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 93,902 | $435,000 | 0.01% |